This summer Allison Isola had the opportunity to join the Therapeutic Areas as a graduate student intern at Novartis. She is working on determining the potential safety risks of inhibiting specific kinases when treating cancer. During this internship she has had great opportunity to interact with Novartis scientists among the different departments, and broaden her scope on different aspects of preclinical safety in drug development.